FIP works closely with the press to support accurate, timely and impactful reporting on pharmacy practice, pharmacy education and pharmaceutical science and global health developments. FIP provides journalists and media professionals with access to policy developments, research, publications, campaigns and initiatives shaping health care worldwide.
FIP also supports media engagement through dedicated press registration and press benefits during the annual FIP world congress, offering accredited journalists opportunities to access scientific sessions, interviews with global pharmacy leaders and key developments from across the profession.
If you would like to join our press list to receive press releases, please email press@fip.org with your name, publication, job title and email address.
The Hague • 2 October 2024
The role of pharmacists in improving access to safe and quality essential medicines and medical devices is the focus of a new reference document published by the International Pharmaceutical Federation (FIP) today.
The publication contains case studies from Australia, Egypt, Malaysia, the Netherlands, South Africa and Spain, presenting the current situation of access to essential medicines, including related regulations and impact of pharmacists in each country.
“Access to essential medicines and medical devices is vital for managing health conditions, preventing diseases, and improving well-being. Essential Medicines Lists serve as a foundation for promoting equitable access to healthcare and addressing the most pressing health needs within a population. This document highlights the importance of access to essential medicines. It also outlines the role of FIP in improving access and addressing the challenges and issues that exist around it,” said Mr Lars-Åke Söderlund, FIP vice president and co-chair of the FIP committee that developed the reference document.
The reference document also looks at capacity building for improved access to pharmaceutical expertise, including new roles for pharmacists in light of developments in public health and technology.
“Access to medicines, devices and services is FIP Development Goal 18. Access to medicines is integral to achieving universal health coverage. This document can be used as an advocacy tool for overcoming barriers hindering access,” Mr Söderlund added.
Notes for editors
About FIP The International Pharmaceutical Federation (FIP) is the global federation of national associations of pharmacists, pharmaceutical scientists and pharmacy educators, and is in official relations with the World Health Organization. Through its 160 member organisations, it represents over four million practitioners and scientists around the world. www.fip.org
PRESS CONTACT
Ms Lin-Nam Wang
Head of Communications and Advocacy
International Pharmaceutical Federation (FIP)
Email linnam@fip.org